← Eichor
Study identifier: NCT07236671 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Progression Patterns of Choroidal Venous Alterations

Condition: Pachychoroid Disease  ·  Sponsor: Singapore National Eye Centre

PhaseN/A
Planned participants250
Who can joinAll sexes, 45 Years to no upper limit
Healthy volunteersNo

About this study

This study is about understanding how a condition called pachychoroid changes over time. Pachychoroid refers to an anatomic choroidal characteristic with abnormally thick choroid or abnormally dilated Haller's vessels. Pachychoroid can range from mild forms which does not cause any problems to more serious ones that might cause vision loss.This study will recruit participants with pachychoroid, to learn more about how this condition develops, how it affects people in the long run, and what factors might make it worse.

This description comes directly from the study's public registry record.

Talk to the study team

Gemmy Cheung  ·  +65 63227460  ·  gemmy.cheung.c.m@singhealth.com.sg

Always discuss trial participation with your own doctor first.

Locations (4)

Hong Kong UniversityHong Kong, Hong KongRecruiting
University of Malaya Medical CentreKuala Lumpur, MalaysiaRecruiting
National University Hospital, SingaporeSingapore, SingaporeRecruiting
Singapore National Eye Centre/ Singapore Eye Research InstituteSingapore, SingaporeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07236671